Trends in RA patients’ adherence to subcutaneous anti-TNF therapies and costs

Author： Borah Bijan J.   Huang Xingyue   Zarotsky Victoria   Globe Denise  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.6, 2009-06, pp. : 1365-1377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

To (anti‐)TNF or not (anti‐)TNF? That is the question in pemphigus

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 564-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of anti‐TNF therapy in elderly patients with inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 441-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 613-623

John Wiley & Sons Inc

Access to resources Recommend Favorite

Self-assessment of 28-joint disease activity scores by patients with rheumatoid arthritis on anti-TNF therapy

By Shaffu Shireen   Edwards Jill   Neame Rebecca   Hassan Waji  

British Journal of Rheumatology , Vol. 52, Iss. 3, 2013-03 ,pp. : 576-578

Oxford University Press

Access to resources Recommend Favorite

Adverse Dermatological Reactions in Rheumatoid Arthritis Patients Treated with Etanercept, an Anti-TNF Drug

By  

Current Drug Safety, Vol. 1, Iss. 3, 2006-08 ,pp. : 259-264

Bentham Science Publishers

Access to resources Recommend Favorite